Brought to you by 
Series D brings in $30mm so far for Proteus Biomedical
21 Apr 2021
Executive Summary
Proteus Biomedical (MEMS devices for cardiovascular, respiratory, metabolic, and neurology conditions and cancer) has closed the first tranche of its Series D venture round. The company received more than $32mm from St. Jude Medical's Pacesetter division and other new corporate investors such as Medtronic and Itochu, as well as current backers Adams Street Partners, Carlyle Group, Essex Woodlands Health Ventures, Kaiser Permanente Ventures, and Spring Ridge Ventures.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Monitoring Equipment & Devices
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series D brings in $30mm so far for Proteus Biomedical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice